TheMediaLine
WHAT WOULD YOU GIVE TO CHANGE THE MISINFORMATION
about the
ISRAEL-HAMAS WAR?

Pfizer files for emergency use authorization for antiviral pill

Pfizer filed an application for emergency use authorization for its experimental antiviral pill against the coronavirus with the US Food and Drug Administration. In clinical trials the oral drug, called Paxlovid, cut the chance of hospitalization or death for adults at risk of getting a severe case of the virus by 89%. It is not known how long it will take for USFDA regulators to rule on the application. Pfizer also has requested emergency use authorization in several other countries, including authorization of the treatment in several countries including the United Kingdom, Australia, New Zealand and South Korea. It will manufacture some 50 million courses of the drug by the end of 2022.

TheMediaLine
WHAT WOULD YOU GIVE TO CHANGE THE MISINFORMATION
about the
ISRAEL-HAMAS WAR?
Personalize Your News
Upgrade your experience by choosing the categories that matter most to you.
Click on the icon to add the category to your Personalize news
Browse Categories and Topics